Exact Sciences‘ Oncotype DX Genomic Prostate Score (GPS) test is a strong independent predictor of critical outcomes in UFI-risk prostate cancer patients, the company announced today. The results of the study–which included 299…
Cellectar Biosciences today announced the effective prices of $1.15 per share of common stock and one-half of a Series H Warrant of an underwritten public offering to raise approximately $20…
Cellectar Biosciences announced today that it has received a European patent for the composition of matter and use protection for the treatment and/or diagnosis of cancer and cancer stem cells for…
The U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE Medical Technologies by October 2021, the company announced today….
Nimble Therapeutics will collaborate with Roche Diagnostics to accelerate the discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays, the company announced today. SARS-CoV-2 is…
Nimble Therapeutics and Swedish company Svar Life Science are collaborating to discover, develop and commercialize diagnostic tests based on Nimble’s novel biomarker discovery engine, the company announced today. “We are…
FluGen, along with Bharat Biotech and virologists at the University of Wisconsin, has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu, the company announced recently….
Exact Sciences is one of four organizations to participate in Gov. Tony Evers’ new public-private partnership to increase Wisconsin’s laboratory testing capacity for COVID-19, the governor announced recently. According to…
BioForward will provide personal protection equipment to Madison-area organizations that serve people with developmental disabilities and seniors, the organization announced recently. “The vulnerable people these organizations assist are at risk…
BrightStar Wisconsin Foundation announced recently that it has invested in Stem Pharm, Inc. Financial terms were not disclosed. As previously reported, the biotech company focuses on creating adult stem cell-derived neural…
